Cite
MLA Citation
Danielle P. Porter et al.. “96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects.” HIV clinical trials, vol. 16, no. 1, 2015, pp. 30–38. http://access.bl.uk/ark:/81055/vdc_100048149043.0x000001